Market Exclusive

Adverum Biotechnologies Inc (NASDAQ:ADVM) price target raised to $10.00 by Chardan Capital

Analyst Ratings For Adverum Biotechnologies Inc (NASDAQ:ADVM)

Today, Chardan Capital raised its price target on Adverum Biotechnologies Inc (NASDAQ:ADVM) to $10.00 per share.

There are 4 Hold Ratings, 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Adverum Biotechnologies Inc (NASDAQ:ADVM) is Hold with a consensus target price of $9.50 per share, a potential 55.99% upside.

Some recent analyst ratings include

Recent Trading Activity for Adverum Biotechnologies Inc (NASDAQ:ADVM)
Shares of Adverum Biotechnologies Inc closed the previous trading session at 6.09 up +0.80 15.12% with shares trading hands.

Exit mobile version